2-氨基-3-(4-氯苯基)丙酸盐酸盐 | 23633-07-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-氨基-3-(4-氯苯基)丙酸盐酸盐
• 英文名称: 2-amino-3-(4-chlorophenyl)propionic acid hydrochloride
• 英文别名: 4-chloro-phenylalanine ; hydrochloride；4-Chlor-phenylalanin; Hydrochlorid；Phenylalanine, 4-chloro-, hydrochloride；2-amino-3-(4-chlorophenyl)propanoic acid;hydrochloride
• CAS: 23633-07-0
• 化学式: C₉H₁₀ClNO₂*ClH
• mdl: MFCD01674282
• 分子量: 236.098
• InChiKey: PFOCEDBJFKVRHU-UHFFFAOYSA-N

物化性质

• 熔点：
  254-255 °C

计算性质

• 辛醇/水分配系数(LogP)：
  -0.58
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  64.9
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-氨基-3-(4-氯苯基)丙酸盐酸盐 在 盐酸 、 三乙胺 作用下， 以 乙酸乙酯 为溶剂， 反应 4.0h， 生成 2-(2-aminobenzoylamino)-3-(4-chlorophenyl)propionic acid ethyl ester
  参考文献：
  名称：

  Anthranilic acid based CCK1 receptor antagonists: preliminary investigation on their second “touch point”

  摘要：

  In this phase of structure-affinity relationship study of VL-0395, a new anthranilic acid based CCK1 selective antagonist, we propose a series Of Unnatural aminoacidic derivatives. The result of this work is the identification of a new CCK ligand, which possesses an affinity (IC50 = 35 nm) one order of magnitude greater than the lead and, as a general rule, it points out how the hypothesized receptorial pocket which accommodates the Phe residue allows much more structural modification than that interacting with the N-terminal group. Hence, the modification of the C-terminal pharmacophoric group of our lead VL-0395 can not only enhance the affinity of anthranific acid derivatives but can modulate the selectivity for one CCK receptor subtype or afford mixed antagonists. (c) 2005 Elsevier SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2005.01.002
• 作为产物：
  描述：

  2-acetylamino-2-(4-chlorobenzyl)malonic acid diethyl ester 在 盐酸 作用下， 以 1,4-二氧六环 、 水 为溶剂， 以56%的产率得到2-氨基-3-(4-氯苯基)丙酸盐酸盐
  参考文献：
  名称：

  Anthranilic acid based CCK1 receptor antagonists: preliminary investigation on their second “touch point”

  摘要：

  In this phase of structure-affinity relationship study of VL-0395, a new anthranilic acid based CCK1 selective antagonist, we propose a series Of Unnatural aminoacidic derivatives. The result of this work is the identification of a new CCK ligand, which possesses an affinity (IC50 = 35 nm) one order of magnitude greater than the lead and, as a general rule, it points out how the hypothesized receptorial pocket which accommodates the Phe residue allows much more structural modification than that interacting with the N-terminal group. Hence, the modification of the C-terminal pharmacophoric group of our lead VL-0395 can not only enhance the affinity of anthranific acid derivatives but can modulate the selectivity for one CCK receptor subtype or afford mixed antagonists. (c) 2005 Elsevier SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2005.01.002

文献信息

• [EN] SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME<br/>[FR] TRIAZOLES AMINO-SUBSTITUÉS ET PROCÉDÉS D'UTILISATION
  申请人：INST DRUG DELIVERY

  公开号：WO2015095701A1

  公开（公告）日：2015-06-25

  Disclosed are novel substituted amino triazoles of Formula (I), and pharmaceutically acceptable salts thereof. The compounds of Formula (I) are inhibitors of Acidic mammalian chitinase (AMCase) and are useful, in a non-limiting example, for treating asthma. Also provided are pharmaceutical compositions containing at least one compound of the present invention, or a pharmaceutically acceptable salt, hydrate or solvate thereof, and at least one pharmaceutically acceptable carrier, solvent, adjuvant or diluent, and methods of using such compounds and/or compositions to treat asthma and/or to monitor asthma treatment.

  公开了化合物的新型替代氨基三唑的结构，其化学式为（I），以及其药学上可接受的盐。化合物的化学式（I）是酸性哺乳动物几丁质酶（AMCase）的抑制剂，并且在非限制性示例中用于治疗哮喘。还提供了含有本发明至少一种化合物或其药学上可接受的盐、水合物或溶剂化合物的药物组合物，以及至少一种药学上可接受的载体、溶剂、辅料或稀释剂，并使用这些化合物和/或组合物来治疗哮喘和/或监测哮喘治疗的方法。
• Asymmetric chemoenzymatic synthesis of N-acetyl-α-amino esters based on lipase-catalyzed kinetic resolutions through interesterification reactions
  作者：Marcos Reinaldo da Silva、Marcos Carlos de Mattos、Maria da Conceição Ferreira de Oliveira、Telma Leda Gomes de Lemos、Nágila Maria Pontes Silva Ricardo、Gonzalo de Gonzalo、Iván Lavandera、Vicente Gotor-Fernández、Vicente Gotor

  DOI：10.1016/j.tet.2014.02.012

  日期：2014.4

  transfer catalysts, this compound reacted with several alkyl halides, being benzyltributylammonium chloride identified as the best one for the production of a series of quaternary amino acids in moderate to excellent yields (52–95%). Then, the corresponding N-acetyl-phenylalanine methyl and allyl ester derivatives were obtained through acidic hydrolysis, esterification, and N-acetylation. Rhizomucor miehei

  从容易获得的乙酰氨基氰基乙酸乙酯开始，已经通过四步路线合成了几种苯丙氨酸类似物。在第一个反应中，并使用相转移催化剂，该化合物与几种烷基卤反应，即苄基三丁基氯化铵，被确定为以中等至极高产率（52–95％）生产一系列季氨基酸的最佳选择。然后，通过酸性水解，酯化和N-乙酰化获得相应的N-乙酰基-苯丙氨酸甲基和烯丙基酯衍生物。根瘤菌脂肪酶被认为是用于拆分这些氨基酯的通用酶，通过与丁酸丁酯在乙腈中进行酯交换反应获得最佳结果。发现取决于化合物的化学结构，对立体选择性有很大的影响，对于苯环中的未取代或对位取代，实现了极好的立体选择性，对间硝基衍生物适中，而邻硝基氨基酯则对中等选择性具有中等选择性。不反应。
• Synthesis and antitumor activity of platinum(II) complexes containing substituted ethylenediamine ligands
  作者：Henri Brunner、Peter Hankofer、Ulrich Holzinger、Barbara Treittinger、Helmut Schönenberger

  DOI：10.1016/0223-5234(90)90162-v

  日期：1990.2
• A crystallization-induced asymmetric transformation to prepare (R)-4-chlorophenylalanine methyl ester
  作者：Cynthia A. Maryanoff、Lorraine Scott、Rekha D. Shah、Frank J. Villani Jr

  DOI：10.1016/s0957-4166(98)00343-7

  日期：1998.9

  A second order asymmetric transformation of racemic 4-chlorophenylalanine methyl ester was achieved via salt formation with (2S,3S)-(-)-tartaric acid in the presence of salicylaldehyde to afford the desired (R)-enantiomer of 4-chlorophenylalanine methyl ester in good yield and high enantiomeric purity. (C) 1998 Elsevier Science Ltd. An rights reserved.
• BRUNNER, HENRI;HANKOFER, PETER;HOLZINGER, ULRICH;TREITTINGER, BARBARA;SCH+, EUR. J. MED. CHEM., 25,(1990) N, C. 35-44
  作者：BRUNNER, HENRI、HANKOFER, PETER、HOLZINGER, ULRICH、TREITTINGER, BARBARA、SCH+

  DOI：——

  日期：——

表征谱图